Intelligent Bio Solutions Q1 EPS $(1.04) Misses $(0.64) Estimate, Sales $109.87K Miss $950.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Intelligent Bio Solutions (NASDAQ:INBS) reported Q1 losses of $(1.04) per share, missing the analyst consensus estimate of $(0.64) by 62.5%. This is a 35% increase over losses from the same period last year. The company also reported quarterly sales of $109.87K, missing the analyst consensus estimate of $950.00K by 88.43%. This is a 64.71% decrease over sales from the same period last year.
November 08, 2023 | 10:38 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intelligent Bio Solutions reported a larger than expected loss and lower than expected sales for Q1. This could negatively impact the company's stock price in the short term.
Intelligent Bio Solutions reported a larger than expected loss and lower than expected sales for Q1. This indicates that the company is not performing as well as expected, which could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100